Colorectal Cancer Clinical Trials in Detroit

Showing 61-80 of 331 trials

F-Tryptophan PET/CT in Human Cancers

NCT05556473

Imaging procedures such as 1-(2-\[18F\]FLUOROETHYL)-L-Tryptophan PET/CT in patients with cancers may help doctors assess a patient's response to treatment and help plan the best treatment in the future. The purpose is to see if there can be a better differentiation of tumor and non-tumor tissue where the tumor tissue has a higher uptake of Tryptophan.

Intracranial GliomaMetastatic Brain TumorBreast Cancer+2 more

Barbara Ann Karmanos Cancer Institute24 participantsStarted Sep 2022

Detroit, Michigan, United States

RECRUITINGPhase 1< 1 mile

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

NCT06974110

This Phase 1, multi-center, open-label, dose escalation and dose optimization study is designed to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx), and preliminary clinical activity of MOMA-341 administered orally as a single agent or combination therapy in patients with microsatellite instability high (MSI-H) or DNA mismatch repair deficiency (dMMR) solid tumors.

Advanced Solid TumorMetastatic Solid TumorEndometrial Cancer+4 more

MOMA Therapeutics132 participantsStarted Jul 2025

Tampa, Florida, United States • Detroit, Michigan, United States • St Louis, Missouri, United States +10 more locations

F-Tryptophan PET/CT in Human Cancers

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Colorectal Cancer Trials in Other Cities

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

Prevention of Colorectal Cancer Through Multiomics Blood Testing

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

EXoPERT EMERALD Clinical Study

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA

The PharmFIT Study

Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening

Other Conditions in Detroit